Prothena Reports Third-Quarter 2026 Financial Results
Prothena reported financial results for the third quarter and first nine months of 2026.
Prothena Corporation plc (NASDAQ:PRTA), a late-stage clinical biotechnology company with a robust pipeline of investigational therapeutics built on protein dysregulation expertise, today reported financial results for the third quarter and first nine months of 2026 and provided business highlights…